Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × anetumab ravtansine × Clear all

NCT03455556 2023-01-06

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Phase 1 Terminated

1 enrolled 1 chart

Carcinoma, Non-Small-Cell Lung